Filed 01 Aug 2026
- Board approved INR 600cr QIP for deleveraging and growth capex; peak net debt expected 1,000-1,500cr post QIP
- Base business FY27 guidance revised to INR 950-1,050cr revenue; FY28 expected 10-15% growth; EBITDA margin ~18%
- Battery chemicals EBITDA ROCE target 20% at full utilization by FY29
- Dahej plant rebuild near completion; commercial production starts Q2 FY27; insurance claims receivable 186cr
- Battery chemicals revenue 19cr in Q1, expected 300cr in FY27; electrolyte plant commissioning H1 FY27, salts H2 FY27
- Battery business revenue potential INR 2,400-2,900cr by FY29 at full utilization; 50% of 2025 revenue in Q1 FY27